Now Enrolling in San Juan, Puerto Rico
Participate in a groundbreaking clinical study that could help advance treatment options for Graves' disease. Qualified participants receive comprehensive medical care, all study medication at no cost, and compensation for their time.
Graves' disease is an autoimmune disorder that causes the thyroid gland to produce too much thyroid hormone (hyperthyroidism). This overproduction leads to a variety of symptoms that can significantly impact quality of life. Our clinical trial is investigating new approaches to manage this condition more effectively.
Heart palpitations and elevated resting heart rate
Unintended weight loss despite increased appetite
Nervousness, irritability, and mood changes
Excessive sweating and discomfort in warm environments
Persistent tiredness despite adequate sleep
Shaking or trembling, especially noticeable during activities
Bulging eyes, dryness, or vision changes
Visible swelling in the neck area (goiter)
Based on your answers, you may be eligible for our clinical trial. The next step is to speak with one of our coordinators who can assess your complete medical history.
Based on your answers, you may not meet the current eligibility criteria. However, we encourage you to reach out—there may be other options available, or you could be eligible for future trials.
Up to $150 per visit to compensate for your time and travel
All study medication provided at no cost to you
Free medical care and supervision by experienced clinicians
All laboratory tests and health monitoring included
Contribute to advancing treatment options for Graves' disease
Access to your health results and detailed study findings
A clinical trial is a research study designed to evaluate the safety and effectiveness of a new medical treatment or intervention. Participants receive investigational medication or treatment while researchers carefully monitor their health and collect data. Our Graves' disease trial follows strict FDA regulations and ethical guidelines to ensure participant safety and the integrity of the research.
Yes. All study medications have undergone extensive pre-clinical and early clinical testing before reaching this trial phase. The medication is monitored by an independent Data Safety Monitoring Board, and we conduct regular safety assessments throughout the trial. You have the right to withdraw at any time if you have concerns about safety. Our medical team is on call to address any questions or adverse events.
This trial does not use a placebo. All participants receive active study medication. However, you will continue receiving your current anti-thyroid medication as well, ensuring you maintain your standard of care throughout the trial. This is a combination therapy study designed to assess the effectiveness of adding the investigational treatment to your existing regimen.
Absolutely. Participation is completely voluntary. You can withdraw from the trial at any time without penalty or loss of benefits. We will work with you and your physician to ensure a safe transition if you decide to discontinue. Your ongoing care will not be affected by your withdrawal decision.
The active treatment phase of the trial lasts 24 weeks (approximately 6 months), with an additional 4-week follow-up period. You will be required to attend study visits approximately every 2 weeks during the treatment phase. Total time commitment is manageable and flexible around your schedule. We also offer compensation for travel and time.
We take your privacy seriously. All personal and medical information is kept strictly confidential and encrypted. Your data is coded and identified only by a participant ID in research databases. The study complies with HIPAA regulations and other applicable privacy laws. You will sign an informed consent form explaining all privacy protections before enrollment.
Your application has been received. A coordinator will contact you within 24 hours. Check your email for confirmation.
Be the first to hear about new clinical trials
Thank you for joining our study alert list. We'll notify you about new clinical trials.